|
Name |
10-epi-gamma-Eudesmol
|
Molecular Formula | C15H26O | |
IUPAC Name* |
2-[(2R,4aS)-4a,8-dimethyl-2,3,4,5,6,7-hexahydro-1H-naphthalen-2-yl]propan-2-ol
|
|
SMILES |
CC1=C2C[C@@H](CC[C@@]2(CCC1)C)C(C)(C)O
|
|
InChI |
InChI=1S/C15H26O/c1-11-6-5-8-15(4)9-7-12(10-13(11)15)14(2,3)16/h12,16H,5-10H2,1-4H3/t12-,15+/m1/s1
|
|
InChIKey |
WMOPMQRJLLIEJV-DOMZBBRYSA-N
|
|
Synonyms |
10-epi-gamma-Eudesmol; epi-Eudesmol; 15051-81-7; 10-epi-eudesm-4-en-11-ol; 2-[(2R,4aS)-4a,8-dimethyl-2,3,4,5,6,7-hexahydro-1H-naphthalen-2-yl]propan-2-ol; 2-((2R,4AS)-4a,8-dimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-yl)propan-2-ol; 2-[(2R,4aS)-4a,8-dimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-yl]propan-2-ol; epi-10- .gamma.-Eudesmol; SCHEMBL310948; CHEBI:62514; (-)-10-epi- .gamma.-eudesmol; ZINC15209455; AKOS032948531; (2R-trans)-1,2,3,4,4a,5,6,7-Octahydro-alpha,alpha,4a,8-tetramethyl-2-naphthalenemethanol; 2-Naphthalenemethanol, 1,2,3,4,4a,5,6,7-octahydro-alpha,alpha,4a,8-tetramethyl-, (2R-trans)-; C19893; Q27131975
|
|
CAS | 15051-81-7 | |
PubChem CID | 6430754 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 222.37 | ALogp: | 3.4 |
HBD: | 1 | HBA: | 1 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 20.2 | Aromatic Rings: | 2 |
Heavy Atoms: | 16 | QED Weighted: | 0.639 |
Caco-2 Permeability: | -4.592 | MDCK Permeability: | 0.00001420 |
Pgp-inhibitor: | 0.032 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.783 |
30% Bioavailability (F30%): | 0.037 |
Blood-Brain-Barrier Penetration (BBB): | 0.209 | Plasma Protein Binding (PPB): | 94.08% |
Volume Distribution (VD): | 1.5 | Fu: | 2.98% |
CYP1A2-inhibitor: | 0.107 | CYP1A2-substrate: | 0.32 |
CYP2C19-inhibitor: | 0.126 | CYP2C19-substrate: | 0.905 |
CYP2C9-inhibitor: | 0.176 | CYP2C9-substrate: | 0.22 |
CYP2D6-inhibitor: | 0.057 | CYP2D6-substrate: | 0.079 |
CYP3A4-inhibitor: | 0.183 | CYP3A4-substrate: | 0.331 |
Clearance (CL): | 10.989 | Half-life (T1/2): | 0.174 |
hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.317 |
Drug-inuced Liver Injury (DILI): | 0.035 | AMES Toxicity: | 0.003 |
Rat Oral Acute Toxicity: | 0.032 | Maximum Recommended Daily Dose: | 0.176 |
Skin Sensitization: | 0.392 | Carcinogencity: | 0.271 |
Eye Corrosion: | 0.861 | Eye Irritation: | 0.887 |
Respiratory Toxicity: | 0.94 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002195 | 0.660 | D07QKN | 0.415 | ||||
ENC002420 | 0.387 | D02VPX | 0.268 | ||||
ENC001013 | 0.387 | D05BTM | 0.263 | ||||
ENC002249 | 0.375 | D0T2PL | 0.263 | ||||
ENC002097 | 0.365 | D0N1TP | 0.263 | ||||
ENC000511 | 0.358 | D02ZGI | 0.263 | ||||
ENC004619 | 0.354 | D0S7WX | 0.235 | ||||
ENC000860 | 0.348 | D04GJN | 0.233 | ||||
ENC002989 | 0.333 | D0K0EK | 0.229 | ||||
ENC002248 | 0.333 | D0G3PI | 0.229 |